Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHELSEA DIANNE GAWRYLETZ

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1801180351
CMS profile
308889
Location
FORT COLLINS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$80,803.69

62 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $40,692.85 27
AstraZeneca Pharmaceuticals LP $23,304.76 18
Stemline Therapeutics Inc. $8,500.58 7
Daiichi Sankyo Inc. $8,293.62 9
PFIZER INC. $11.88 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

62 matching records · $80,803.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 62 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 62.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $1,200.0012/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600822 CMS
Gilead Sciences, Inc. $20.8212/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133643586 CMS
Gilead Sciences, Inc. $113.5212/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133643588 CMS
Gilead Sciences, Inc. $113.7412/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133643584 CMS
Daiichi Sankyo Inc. $4,020.0012/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089424997 CMS
Stemline Therapeutics Inc. $5,580.0012/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261238808608 CMS
Stemline Therapeutics Inc. $256.9512/10/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261238808610 CMS
Stemline Therapeutics Inc. $738.0712/10/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261238808612 CMS
Daiichi Sankyo Inc. $1,303.4012/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089424991 CMS
Daiichi Sankyo Inc. $119.0812/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089424995 CMS
Gilead Sciences, Inc. $3,950.0011/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600820 CMS
Daiichi Sankyo Inc. $2,680.0010/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089424999 CMS
Stemline Therapeutics Inc. $5.3310/25/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142958980 CMS
AstraZeneca Pharmaceuticals LP $5,360.0010/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105487617 CMS
AstraZeneca Pharmaceuticals LP $1,110.0010/19/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104490220 CMS
Stemline Therapeutics Inc. $54.9010/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142958978 CMS
AstraZeneca Pharmaceuticals LP $1,571.8010/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105658654 CMS
AstraZeneca Pharmaceuticals LP $119.8310/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105805408 CMS
Gilead Sciences, Inc. $1,980.0010/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600818 CMS
Stemline Therapeutics Inc. $5.3310/07/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142958982 CMS
Daiichi Sankyo Inc. $10.2710/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089424989 CMS
Daiichi Sankyo Inc. $124.6910/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089424993 CMS
Stemline Therapeutics Inc. $1,860.0009/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142958976 CMS
Gilead Sciences, Inc. $6,720.0008/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600816 CMS
AstraZeneca Pharmaceuticals LP $1,665.0008/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105648318 CMS
Daiichi Sankyo Inc. $14.5907/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089425005 CMS
Gilead Sciences, Inc. $1,980.0007/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600814 CMS
Gilead Sciences, Inc. $387.9207/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133857928 CMS
Gilead Sciences, Inc. $1,014.1607/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133857930 CMS
AstraZeneca Pharmaceuticals LP $2,200.0007/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104768146 CMS
AstraZeneca Pharmaceuticals LP $34.8407/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104381669 CMS
AstraZeneca Pharmaceuticals LP $124.9407/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105256426 CMS
PFIZER INC. $11.8807/09/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132059810 CMS
Gilead Sciences, Inc. $1,980.0006/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600812 CMS
AstraZeneca Pharmaceuticals LP $3,350.0006/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105759647 CMS
AstraZeneca Pharmaceuticals LP $106.4505/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104720085 CMS
AstraZeneca Pharmaceuticals LP $776.1305/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105581420 CMS
AstraZeneca Pharmaceuticals LP $2,200.0005/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104252469 CMS
AstraZeneca Pharmaceuticals LP $124.6905/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104516402 CMS
AstraZeneca Pharmaceuticals LP $450.0005/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104636063 CMS
AstraZeneca Pharmaceuticals LP $34.8405/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105438533 CMS
Gilead Sciences, Inc. $8,160.0005/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600810 CMS
Gilead Sciences, Inc. $1,980.0005/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133600808 CMS
AstraZeneca Pharmaceuticals LP $3,350.0005/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105341123 CMS
Daiichi Sankyo Inc. $8.9005/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089425003 CMS
AstraZeneca Pharmaceuticals LP $674.1105/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104309226 CMS
Gilead Sciences, Inc. $55.0504/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133643582 CMS
Gilead Sciences, Inc. $7.8004/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133643572 CMS
Gilead Sciences, Inc. $14.9804/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133643574 CMS
Gilead Sciences, Inc. $24.8904/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133643576 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,001.77 10
PY2020 $4,845.58 8
PY2021 $27,631.71 45
PY2022 $85,307.27 71
PY2023 $74,157.78 52
PY2024 $80,803.69 62
PY2025 $27,638.74 31

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
CHELSEA DIANNE GAWRYLETZ, NPI 1801180351. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1801180351.
APA 7
IndustryPayments. (2026). CHELSEA DIANNE GAWRYLETZ, NPI 1801180351 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1801180351
Bluebook
CHELSEA DIANNE GAWRYLETZ, NPI 1801180351, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1801180351.

Source: Centers for Medicare & Medicaid Services, Open Payments.